Connection

Scott Bradley to Anticholesteremic Agents

Back to Details
This is a "connection" page, showing publications Scott Bradley has written about Anticholesteremic Agents.
Scott Bradley
Connection Strength
0.082
Anticholesteremic Agents
  1. Pharmacokinetics, metabolism, and excretion of anacetrapib, a novel inhibitor of the cholesteryl ester transfer protein, in rats and rhesus monkeys. Drug Metab Dispos. 2010 Mar; 38(3):459-73.
    View in: PubMed
    Score: 0.082
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.